Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
©2013 UpToDate ® Print Email ASCO Guidelines for monitoring with DXA scans in women in breast cancer Monitoring indicated for: Women over age 65 years Women ages 60 to 64 years with the one or more of the following: Family history of osteoporosis Low body weight less than 70 kg Prior non-traumatic fracture Other risk factors such as sedentary, smoking Postmenopausal women on AI Premenopausal women who develop treatment-related premature menopause ASCO: American Society of Clinical Oncology; AI: aromatase inhibitor. Reproduced with permission from: Pant, S, Shapiro, CL. Aromatase inhibitor-associated bone loss. Drugs 2008; 68:2591. Copyright ©2008 Adis Data Information BV.